Skip to main content

Month: September 2022

Brixton Metals Announces Oversubscribed Second and Final Closing of $2,631,843 for an Aggregate $6,145,381 Private Placement Financing with Lead Order from Crescat Capital

Not for distribution to United States Newswire Services or for dissemination in the United States VANCOUVER, British Columbia, Sept. 15, 2022 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) announces that, subject to final approval of the TSX Venture Exchange (the “Exchange”), the Company has closed the second tranche of a non-brokered private placement for aggregate proceeds of $2,631,843.23 (“Second Tranche Private Placement”) consisting of 19,495,135 units (“Units”) at a price of $0.135. Each Unit will consist of one common share and one common share purchase warrant, each warrant being exercisable for an additional common share of the Company for $0.20 for 24 months from the date of issuance of the Units. Brixton’s current largest shareholder, Crescat Portfolio Management...

Continue reading

Sorrento Announces the Publication in the Nature Journal Scientific Reports the Details of the Discovery of SARS-CoV-2 Neutralizing Antibodies from the G-MAB Library

SAN DIEGO, Sept. 15, 2022 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced publication of peer-reviewed data detailing the discovery and preclinical profiling of antibodies from the Sorrento G-MAB™ library with neutralizing activity against SARS-CoV-2 in vitro and in vivo in Scientific Reports, a Nature portfolio journal. The full publication is available at: https://rdcu.be/cVEl6 About Sorrento Therapeutics, Inc.  Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19. Sorrento’s multimodal, multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as next-generation tyrosine kinase...

Continue reading

Rivalry to Host Virtual Investor Day on October 6, 2022

TORONTO, Sept. 15, 2022 (GLOBE NEWSWIRE) — Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), an internationally regulated sports betting and media company, today announced that it plans to host a Virtual Investor Day on Thursday, October 6, 2022, beginning at 10:00 am EDT. Held one year after Rivalry’s public listing, the Company’s inaugural Investor Day will include presentations and commentary from a cross-section of the leadership team. The sessions will provide insights into Rivalry’s growth over the past year, the key elements of its strategy, and the initiatives expected to drive growth into 2023 and beyond. The Investor Day event is expected to last approximately 1.5 to 2 hours. Participants may register in advance to view the listen-only webcast by visiting the Events section of Rivalry’s...

Continue reading

WEST MINING ANNOUNCES AGM RESULTS

Vancouver, B.C., Sept. 15, 2022 (GLOBE NEWSWIRE) — West Mining Corp. (“West” or the “Company”) (CSE: WEST) (OTC: WESMF) is pleased to announce the results of its Annual General Meeting of Shareholders held on September 14, 2022. Over 90% of the shareholders that voted at the AGM approved all of the resolutions presented: setting the number of directors at three; re-electing each of Nicholas Houghton, Alex Klenman and Andrew Lee Smith to the Company’s board of directors; and re-appointing Manning Elliot LLP as the Company’s auditor. The Company also announces that it has adopted a Restricted Share Unit Plan. The aggregate number of Company shares that may be reserved for issuance, at any time, under the RSU Plan and under any other share compensation arrangement adopted by the Company, including the Company’s incentive stock option...

Continue reading

Coveo Announces Voting Results for 2022 Annual General Meeting of Shareholders

MONTREAL and SAN FRANCISCO, Sept. 15, 2022 (GLOBE NEWSWIRE) — Coveo Solutions Inc. (“Coveo” or the “Corporation”) (TSX: CVO), a leader in AI-powered relevance platforms that helps to transform search, recommendations, personalization and merchandising within digital experiences, today announced the voting results for its annual general meeting of shareholders held on September 15, 2022 (the “Meeting”). The detailed results of the votes held at the Meeting are set out below. 1.   Election of Directors According to votes received, each of the following nine (9) nominees proposed by management was duly elected as a director of the Corporation until the next annual meeting of shareholders, or until such person’s successor is elected or appointed, with the following results:Director # of Votes For % of Votes Cast For # of Votes Against % of Votes Cast AgainstLouis...

Continue reading

Bombardier Defense Delivers High-performance Global Aircraft to the U.S. Air Force Battlefield Airborne Communications Node (BACN) Program

Bombardier Defense Delivers High-performance Global Aircraft to the U.S. Air Force Battlefield Airborne Communications Node (BACN) Program Steve Patrick, VP of Bombardier Defense welcomes Lt Col Eric Inkenbrandt, USAF BACN Material Leader to cut the ribbon and celebrate their new Global 6000 BACN aircraft.Aircraft delivery is the first as part of an order from the USAF, announced in June 2021, to modify up to six Global 6000 business jets. The 2021 contract, representing a potential total value of close to $465 million U.S., included an immediate firm order for one Global 6000 aircraft with subsequent additional firm orders announced in April 2022Bombardier Global business jets have become a go-to platform for special missions around the world, thanks to their speed, payload capacity, built-in power redundancy, reliability and enduranceWICHITA,...

Continue reading

Celularity Enters Into $150 Million Pre-Paid Advance Agreement with Yorkville

FLORHAM PARK, N.J., Sept. 15, 2022 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a clinical-stage biotechnology company developing placental-derived allogeneic cell therapies, today announced that it entered into a Pre-Paid Advance Agreement (the “Agreement”) with YA II PN, LTD (“Yorkville”), an affiliate of Yorkville Advisors Global, LP. Under the Agreement, Celularity may request individual pre-paid advances from Yorkville in an amount up to $40 million each subject to certain conditions, up to $150 million over the next eighteen (18) months from time to time and as mutually agreed by the parties. Pre-paid advances are issued at a 2% discount, bear interest at a rate of 6% (increased to 15% in the event of default). If at any time during the 18-month commitment period there is an outstanding balance under...

Continue reading

ExGen: Empire Mine Project Moving Closer to Production

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 15, 2022 (GLOBE NEWSWIRE) — ExGen Resources Inc. (TSX.V: EXG; OTC: BXXRF) (“ExGen”, the “Company”) is pleased to provide an update in respect of Phoenix Copper Ltd.’s (“Phoenix”) exploration and development activities at the Empire Mine Project in Custer County, Idaho, USA. Further to previous ExGen news releases, ExGen owns 20% and Phoenix owns 80% of Konnex Resources, Inc. (“Konnex”), which holds the leases and claims to the Empire Mine Project. ExGen further owns 1,330,000 common shares of Phoenix. The following program highlights were provided by Phoenix: Highlights:Drilling at the Empire open pit copper mine (“Empire”) commenced in June 2022 to further Konnex’s understanding of metallurgical...

Continue reading

PRESS RELEASE: BIGBEN : Capital reduction by cancellation of treasury shares

                                                Press release       Lesquin, 15 September 2022 – 18:00 hrs Capital reduction by cancellation of treasury shares The Board of Directors of Bigben Interactive meeting on 15th September 2022 has, pursuant to authorization from the combined general meeting dated July 22, 2022 under the terms of its 30th resolution, decided to reduce the share capital of the Company by cancelling 173,568 treasury shares purchased between May 28, 2022 and July 20, 2022 and representing approximately 0.93% of the share capital of Bigben Interactive. All of the 173,568 cancelled shares were purchased on the Euronext market in Paris, in accordance with the share purchase mandate given by the Company to CIC Market Solutions, as part of the share buyback programme implemented by a decision of the Board of Directors...

Continue reading

Proactive news headlines including Kanye West, Cinedigm, Hapbee Technologies, PyroGenesis, Tiziana Life Sciences and ION Energy

New York , Sept. 15, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:American rapper Kanye West to cut ties with Gap over alleged contractual breaches click here Avicanna collaborates with University of Toronto to expand its epilepsy research program click here Sigma Lithium adds veteran finance executive Dana Perlman to its board of directors click here Cinedigm debuts free streaming service Cineverse, plans to add more than 10,000 films and TV episodes by year end click here Hapbee Technologies extends device line-up with Hapbee Smart Sleep Pad click here Nextleaf to launch Glacial Gold products in Ontario and British Columbia markets click here PyroGenesis ranked amongst the Top 10 best-performing stocks...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.